Endo
US bankruptcy judge approves Purdue Pharma’s $6bn opioid settlement plan
The Sackler family will pay the amount over 18 years to victims of addiction and US states
FDA panel backs Indivior’s drug to fight opioid addiction
The former RB pharma unit hopes for sales in the $1bn region
Endo faces industry-first FDA call to pull its opioid painkiller
Misuse of Opana ER has been associated with a ‘serious’ HIV and hep C outbreaks
Endo buys Par for $8bn as M&A mania marches on
Acquisitionwill make Endo the fifth largest generics company in the US
Endo’s $2.2bn bid for Auxilium Pharma could thwart QLT deal
Auxilium in the $345m process of acquiring Canadian biotech company
Endo opts for Ogilvy PR
Agency will provide PR support for Endo’s men’s health and pain management business